...
首页> 外文期刊>Journal of the American Academy of Dermatology >Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy.
【24h】

Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy.

机译:对厄洛替尼治疗有反应的转移性皮肤鳞状细胞癌。

获取原文
获取原文并翻译 | 示例

摘要

Cutaneous squamous cell carcinoma (SCC) is a common dermatologic condition. Most (>90%) cases are cured by local therapies.1 Therapy is poorly defined if not amenable to local treatment. We present a case of unresectable SCC responding to epidermal growth factor receptor (EGFR) inhibition. After SCC excision from his shoulder, a 47-year-old male developed multiple axillary nodal recurrences that were treated with surgery and chemoradiotherapy. The disease became unresectable because of axillary vessel and brachial plexus involvement. Severe pain 'was constant and only partly controlled with large analgesic doses.
机译:皮肤鳞状细胞癌(SCC)是一种常见的皮肤病。大多数(> 90%)病例可通过局部疗法治愈。1如果不适合局部治疗,则疗法的定义不明确。我们提出了一种不可切除的SCC对表皮生长因子受体(EGFR)抑制的反应。从肩膀上切除SCC后,一名47岁的男性出现了多发性腋窝淋巴结复发,并通过手术和放化疗进行了治疗。由于腋血管和臂丛神经受累,该病无法切除。剧烈疼痛是恒定的,并且仅在大剂量镇痛药的情况下才能部分控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号